What keeps healthcare workers logging in? a trial tests two strategies
NCT ID NCT07791563
First seen Aug 28, 2026 · Last updated Aug 28, 2026
Summary
This trial tests whether personalizing content or adding human support increases how much healthcare workers use a digital mental health program. The program teaches cognitive behavioral skills like activity scheduling and mood tracking. Researchers will compare a standard version, a tailored version, and a tailored version with coaching. Participants use the program weekly for 6 weeks and complete questionnaires at several points to measure engagement and burnout.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- A digital mental health program based on cognitive behavioral therapy, with optional content tailoring and human support coaching
- What this could lead to
- If it works, this could point toward better ways to keep healthcare workers engaged in digital mental health tools, potentially reducing burnout.
- What could go wrong
- The trial is early and focuses on engagement, not direct health outcomes. Results may not apply to all workers, and adding human support may not boost participation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 201 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Nov 2026
An estimate. Start dates often move.
- Expected to finish
-
Mar 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18 years or older, all sexes * Currently working in healthcare in the US with at least 4 hours per week of direct patient contact * Stable access to internet * Have a total score between 3-14 on the PHQ-9 (Patient Health Questionnaire-9), suggestive of mild to moderate depressive symptoms Exclusion Criteria: * Have a total score of ≥15 on the PHQ-9, indicating Severe Depressive symptoms. * Currently diagnosed with a psychotic disorder or bipolar disorder, based on self-report. * Currently receiving psychotherapy for depression or anxiety based on self-report; If on medications for depression or anxiety, must be on a stable dose of medication for at least 2 weeks.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthcare workforce well-being are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Neuropsychiatric Institute
Chicago, Illinois, 60612, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.